IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells

Journal of Experimental Medicine

Volumn 204, Issue 8, 2007, Pages 1837-1847

  Wang, Yui Hsi ^a   Angkasekwinai, Pornpimon ^a,e,g   Lu, Ning ^a   Voo, Kui Shin ^a   Arima, Kazuhiko ^a   Hanabuchi, Shino ^a   Hippe, Andreas ^f   Corrigan, Chris J ^b   Dong, Chen ^a   Homey, Bernhard ^f   Yao, Zhengbin ^c   Ying, Sun ^b   Huston, David P ^d   Liu, Yong Jun ^a,g  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Tanox Biosystems Inc   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e THAMMASAT UNIVERSITY   (Thailand)

^f HEINRICH HEINE UNIVERSITY   (Germany)

^g UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; INTERLEUKIN 25; INTERLEUKIN 4; INTERLEUKIN 7; INTERLEUKIN RECEPTOR; TRANSCRIPTION FACTOR C MAF; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR JUNB;

ALLERGIC DISEASE; ARTICLE; ASTHMA; ATOPIC DERMATITIS; ATOPY; BASOPHIL; CELL TYPE; CYTOKINE RELEASE; DENDRITIC CELL; EOSINOPHIL; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LUNG PARENCHYMA; MEMORY CELL; PRIORITY JOURNAL; PROTEIN SECRETION; SKIN DEFECT; TH2 CELL;

CELL PROLIFERATION; CYTOKINES; DENDRITIC CELLS; EOSINOPHILS; GATA3 TRANSCRIPTION FACTOR; HUMANS; HYPERSENSITIVITY; IMMUNE SYSTEM; IMMUNOLOGIC MEMORY; INFLAMMATION; INTERLEUKIN-17; INTERLEUKIN-4; PROTO-ONCOGENE PROTEINS C-JUN; PROTO-ONCOGENE PROTEINS C-MAF; TH2 CELLS;

EID: 34547820890     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20070406     Document Type: Article

References (29)

1. Cohn, L., J.A. Elias, and G.L. Chupp. 2004. Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 22:789-815.
2. Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17:255-281.
3. Gleich, G.J., C.R. Adolphson, and K.M. Leiferman. 1993. The biology of the eosinophilic leukocyte. Annu. Rev. Med. 44:85-101.
4. Rothenberg, M.E. 1998. Eosinophilia. N. Engl. J. Med. 338:1592-1600.
5. Pan, G., D. French, W. Mao, M. Maruoka, P. Risser, J. Lee, J. Foster, S. Aggarwal, K. Nicholes, S. Guillet, et al. 2001. Forced expression of murine IL-17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice. J. Immunol. 167:6559-6567.
6. Owyang, A.M., C. Zaph, E.H. Wilson, K.J. Guild, T. McClanahan, H.R. Miller, D.J. Cua, M. Goldschmidt, C.A. Hunter, R.A. Kastelein, and D. Artis. 2006. Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J. Exp. Med. 203:843-849.
7. Kim, M.R., R. Manoukian, R. Yeh, S.M. Silbiger, D.M. Danilenko, S. Scully, J. Sun, M.L. DeRose, M. Stolina, D. Chang, et al. 2002. Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production. Blood. 100:2330-2340.
8. Hurst, S.D., T. Muchamuel, D.M. Gorman, J.M. Gilbert, T. Clifford, S. Kwan, S. Menon, B. Seymour, C. Jackson, T.T. Kung, et al. 2002. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J. Immunol. 169:443-453.
9. Fort, M.M., J. Cheung, D. Yen, J. Li, S.M. Zurawski, S. Lo, S. Menon, T. Clifford, B. Hunte, R. Lesley, et al. 2001. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity. 15:985-995.
10. Fallon, P.G., S.J. Ballantyne, N.E. Mangan, J.L. Barlow, A. Dasvarma, D.R. Hewett, A. McIlgorm, H.E. Jolin, and A.N. McKenzie. 2006. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J. Exp. Med. 203:1105-1116.
11. Ikeda, K., H. Nakajima, K. Suzuki, S. Kagami, K. Hirose, A. Suto, Y. Saito, and I. Iwamoto. 2003. Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activation. Blood. 101:3594-3596.
12. Liu, Y.J. 2006. Thymic stromal lymphopoietin: master switch for allergic inflammation. J. Exp. Med. 203:269-273.
13. Ito, T., Y.H. Wang, O. Duramad, T. Hori, G.J. Delespesse, N. Watanabe, F.X. Qin, Z. Yao, W. Cao, and Y.J. Liu. 2005. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J. Exp. Med. 202:1213-1223.
14. Al Shami, A., R. Spolski, J. Kelly, A. Keane-Myers, and W.J. Leonard. 2005. A role for TSLP in the development of inflammation in an asthma model. J. Exp. Med. 202:829-839.
15. Soumelis, V., P.A. Reche, H. Kanzler, W. Yuan, G. Edward, B. Homey, M. Gilliet, S. Ho, S. Antonenko, A. Lauerma, et al. 2002. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat. Immunol. 3:673-680.
16. Ying, S., B. O'Connor, J. Ratoff, Q. Meng, K. Mallett, D. Cousins, D. Robinson, G. Zhang, J. Zhao, T.H. Lee, and C. Corrigan. 2005. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J. Immunol. 174:8183-8190.
17. Yoo, J., M. Omori, D. Gyarmati, B. Zhou, T. Aye, A. Brewer, M.R. Comeau, D.J. Campbell, and S.F. Ziegler. 2005. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J. Exp. Med. 202:541-549.
18. Zhou, B., M.R. Comeau, T. De Smedt, H.D. Liggitt, M.E. Dahl, D.B. Lewis, D. Gyarmati, T. Aye, D.J. Campbell, and S.F. Ziegler. 2005. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat. Immunol. 6:1047-1053.
19. + T cell homeostatic expansion. Nat. Immunol. 5:426-434.
20. Wang, Y.H., T. Ito, Y.H. Wang, B. Homey, N. Watanabe, R. Martin, C.J. Barnes, B.W. McIntyre, M. Gilliet, R. Kumar, et al. 2006. Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells. Immunity. 24:827-838.
21. Moqbel, R., F. Levi-Schaffer, and A.B. Kay. 1994. Cytokine generation by eosinophils. J. Allergy Clin. Immunol. 94:1183-1188.
22. Tamachi, T., Y. Maezawa, K. Ikeda, S. Kagami, M. Hatano, Y. Seto, A. Suto, K. Suzuki, N. Watanabe, Y. Saito, et al. 2006. IL-25 enhances allergic airway inflammation by amplifying a TH2 cell-dependent pathway in mice. J. Allergy Clin. Immunol. 118:606-614.
23. Letuve, S., S. Lajoie-Kadoch, S. Audusseau, M.E. Rothenberg, P.O. Fiset, M.S. Ludwig, and Q. Hamid. 2006. IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts. J. Allergy Clin. Immunol. 117:590-596.
24. MacKenzie, J.R., J. Mattes, L.A. Dent, and P.S. Foster. 2001. Eosinophils promote allergic disease of the lung by regulating CD4(+) Th2 lymphocyte function. J. Immunol. 167:3146-3155.
25. Odemuyiwa, S.O., A. Ghahary, Y. Li, L. Puttagunta, J.E. Lee, S. Musat-Marcu, A. Ghahary, and R. Moqbel. 2004. Cutting edge: human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase. J. Immunol. 173:5909-5913.
26. Cao, W., D.B. Rosen, T. Ito, L. Bover, M. Bao, G. Watanabe, Z. Yao, L. Zhang, L.L. Lanier, and Y.J. Liu. 2006. Plasmacytoid dendritic cell-specific receptor ILT7-FcεRIγ inhibits Toll-like receptor-induced interferon production. J. Exp. Med. 203:1399-1405.
27. Kadowaki, N., S. Antonenko, S. Ho, M.C. Rissoan, V. Soumelis, S.A. Porcelli, L.L. Lanier, and Y.J. Liu. 2001. Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J. Exp. Med. 193:1221-1226.
28. Reche, P.A., V. Soumelis, D.M. Gorman, T. Clifford, M. Liu, M. Travis, S.M. Zurawski, J. Johnston, Y.J. Liu, H. Spits, et al. 2001. Human thymic stromal lymphopoietin preferentially stimulates myeloid cells. J. Immunol. 167:336-343.
29. Bressler, R.B., J. Lesko, M.L. Jones, M. Wasserman, R.R. Dickason, M.M. Huston, S.W. Cook, and D.P. Huston. 1997. Production of IL-5 and granulocyte-macrophage colony-stimulating factor by naive human mast cells activated by high-affinity IgE receptor ligation. J. Allergy Clin. Immunol. 99:508-514.